1. Cutting Edge: TNF Is Essential for Mycobacteria-Induced MINCLE Expression, Macrophage Activation, and Th17 Adjuvanticity
- Author
-
Peter J. Murray, Stefanie Dichtl, Roland Lang, Johanna Schäfer, Ursula R. Sorg, Dennis Christensen, Judith Schick, Klaus Pfeffer, Christian Alexander, and Ulrike Schleicher
- Subjects
Immunology ,Etanercept ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Downregulation and upregulation ,C-type lectin ,Animals ,Tuberculosis ,Immunology and Allergy ,Medicine ,Macrophage ,Lectins, C-Type ,Receptors, Immunologic ,Receptor ,Cells, Cultured ,Mice, Knockout ,Mycobacterium bovis ,biology ,Tumor Necrosis Factor-alpha ,business.industry ,Trehalose ,Macrophage Activation ,biology.organism_classification ,Mice, Inbred C57BL ,Receptors, Tumor Necrosis Factor, Type I ,Th17 Cells ,Sugar Phosphates ,Tumor necrosis factor alpha ,Cytokine secretion ,business ,030215 immunology ,medicine.drug - Abstract
TNF blockade is a successful treatment for human autoimmune disorders like rheumatoid arthritis and inflammatory bowel disease yet increases susceptibility to tuberculosis and other infections. The C-type lectin receptors (CLR) MINCLE, MCL, and DECTIN-2 are expressed on myeloid cells and sense mycobacterial cell wall glycolipids. In this study, we show that TNF is sufficient to upregulate MINCLE, MCL, and DECTIN-2 in macrophages. TNF signaling through TNFR1 p55 was required for upregulation of these CLR and for cytokine secretion in macrophages stimulated with the MINCLE ligand trehalose-6,6-dibehenate or infected with Mycobacterium bovis bacillus Calmette–Guérin. The Th17 response to immunization with the MINCLE-dependent adjuvant trehalose-6,6-dibehenate was specifically abrogated in TNF-deficient mice and strongly attenuated by TNF blockade with etanercept. Together, interference with production or signaling of TNF antagonized the expression of DECTIN-2 family CLR, thwarting vaccine responses and possibly increasing infection risk.
- Published
- 2020
- Full Text
- View/download PDF